Anticoagulant therapy does not extend survival in people with PAH, according to a French study involving the blood thinners.

Death rates and disability in newborn PAH have declined globally since 1990, but inequalities remain, according to a 30-year ...

The term "October slide" refers to a trend in which many in the chronic illness community face health setbacks, writes ...

Experimental treatment ALG-801 was shown to be more effective than approved PAH therapies at reducing signs of disease in an ...

Researchers developed PVC, a measure that estimates the reduced function of the pulmonary arteries in pediatric PAH patients, ...

The strategy begins with medications, followed by balloon pulmonary angioplasty, and pulmonary endarterectomy surgery, a ...

Long-term treatment with Tyvaso DPI is safe and effective in adults with PAH who were previously on Tyvaso, according to ...

Worldwide, pulmonary arterial hypertension affects more than 2 of every 100,000 women and girls of childbearing age, a new study shows.

Pulmonary hypertension (PH) is a rare, life-threatening disease that affects the pulmonary arteries, the lungs, and the heart. Patients who suffer from the disease have narrow and obstructed pulmonary ...